Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Asano-Mori, Y."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-10 z 10
    Tytuł:
    Phase 2 results of lisocabtagene maraleucel in Japanese patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.
    Autorzy:
    Makita S; National Cancer Center Hospital, Tokyo, Japan.
    Yamamoto G; Toranomon Hospital, Tokyo, Japan.
    Maruyama D; National Cancer Center Hospital, Tokyo, Japan.
    Asano-Mori Y; Toranomon Hospital, Tokyo, Japan.
    Kaji D; Toranomon Hospital, Tokyo, Japan.
    Ananthakrishnan R; Bristol Myers Squibb, Princeton, New Jersey, USA.
    Ogasawara K; Bristol Myers Squibb, Princeton, New Jersey, USA.
    Stepan L; Bristol Myers Squibb, Princeton, New Jersey, USA.
    Schusterbauer C; Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland.
    Rettby N; Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland.
    Hasskarl J; Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland.
    Izutsu K; National Cancer Center Hospital, Tokyo, Japan.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2022 Dec; Vol. 11 (24), pp. 4889-4899. Date of Electronic Publication: 2022 May 26.
    Typ publikacji:
    Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Immunotherapy, Adoptive*/adverse effects
    Lymphoma, Large B-Cell, Diffuse*/drug therapy
    Humans ; Antigens, CD19 ; Cytokine Release Syndrome/chemically induced ; Cytokine Release Syndrome/epidemiology ; Receptors, Chimeric Antigen ; Thrombocytopenia/chemically induced ; Thrombocytopenia/epidemiology ; Japan
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Autorzy:
    Kimura M; Department of Infectious Diseases, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan. .
    Araoka H; Department of Infectious Diseases, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.; Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
    Yoshida A; Department of Infection Control and Clinical Laboratory Medicine, Dokkyo Medical University, Tochigi, Japan.
    Yamamoto H; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Abe M; Department of Infectious Diseases, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
    Okamoto Y; Department of Infection Control and Clinical Laboratory Medicine, Dokkyo Medical University, Tochigi, Japan.
    Yuasa M; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Kaji D; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Kageyama K; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Nishida A; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Ishiwata K; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Takagi S; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Yamamoto G; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Asano-Mori Y; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Uchida N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Hishinuma A; Department of Infection Control and Clinical Laboratory Medicine, Dokkyo Medical University, Tochigi, Japan.
    Izutsu K; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Wake A; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Taniguchi S; Department of Hematology, Toranomon Hospital, Tokyo, Japan.; Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
    Yoneyama A; Department of Infectious Diseases, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.; Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
    Pokaż więcej
    Źródło:
    BMC infectious diseases [BMC Infect Dis] 2016 Aug 05; Vol. 16, pp. 372. Date of Electronic Publication: 2016 Aug 05.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Bacteremia/*drug therapy
    Hematologic Neoplasms/*therapy
    Hematopoietic Stem Cell Transplantation/*adverse effects
    Levofloxacin/*therapeutic use
    Streptococcal Infections/*prevention & control
    Viridans Streptococci/*isolation & purification
    Adult ; Aged ; Antibiotic Prophylaxis/methods ; Bacteremia/epidemiology ; Bacteremia/microbiology ; Female ; Hematologic Neoplasms/complications ; Hematologic Neoplasms/epidemiology ; Hospitals ; Humans ; Japan/epidemiology ; Male ; Middle Aged ; Retrospective Studies ; Streptococcal Infections/epidemiology ; Streptococcal Infections/microbiology ; Transplantation Conditioning/methods ; Transplantation, Homologous ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases.
    Autorzy:
    Yamamoto H; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Uchida N; 1] Department of Hematology, Toranomon Hospital, Tokyo, Japan [2] Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
    Matsuno N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Kon A; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Nishida A; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Ota H; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Ikebe T; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Nakano N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Ishiwata K; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Araoka H; Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
    Takagi S; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Tsuji M; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Asano-Mori Y; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Yamamoto G; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Izutsu K; 1] Department of Hematology, Toranomon Hospital, Tokyo, Japan [2] Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
    Masuoka K; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Wake A; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
    Yoneyama A; Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
    Makino S; Department of Transfusion Medicine, Toranomon Hospital, Tokyo, Japan.
    Taniguchi S; 1] Department of Hematology, Toranomon Hospital, Tokyo, Japan [2] Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
    Pokaż więcej
    Źródło:
    Bone marrow transplantation [Bone Marrow Transplant] 2015 Apr; Vol. 50 (4), pp. 607-9. Date of Electronic Publication: 2015 Jan 26.
    Typ publikacji:
    Letter
    MeSH Terms:
    Hematologic Diseases*/mortality
    Hematologic Diseases*/therapy
    Transplantation Conditioning*
    Busulfan/*administration & dosage
    Melphalan/*administration & dosage
    Vidarabine/*analogs & derivatives
    Adult ; Aged ; Cord Blood Stem Cell Transplantation ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Risk Factors ; Survival Rate ; Vidarabine/administration & dosage ; Whole-Body Irradiation
    Opinia redakcyjna
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Relative incidences and outcomes of Clostridium difficile infection following transplantation of unrelated cord blood, unrelated bone marrow, and related peripheral blood in adult patients: a single institute study.
    Autorzy:
    Hosokawa K; Department of Hematology, Toranomon Hospital, Tokyo, Japan; Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
    Takami A
    Tsuji M
    Araoka H
    Ishiwata K
    Takagi S
    Yamamoto H
    Asano-Mori Y
    Matsuno N
    Uchida N
    Masuoka K
    Wake A
    Makino S
    Yoneyama A
    Nakao S
    Taniguchi S
    Pokaż więcej
    Źródło:
    Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2014 Jun; Vol. 16 (3), pp. 412-20. Date of Electronic Publication: 2014 May 09.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Blood Donors*
    Transfusion Reaction*
    Unrelated Donors*
    Bone Marrow Transplantation/*adverse effects
    Clostridium Infections/*etiology
    Cord Blood Stem Cell Transplantation/*adverse effects
    Adult ; Aged ; Aged, 80 and over ; Clostridioides difficile ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Treatment Outcome ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy.
    Autorzy:
    Araoka H; Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan. />Fujii T
    Izutsu K
    Kimura M
    Nishida A
    Ishiwata K
    Nakano N
    Tsuji M
    Yamamoto H
    Asano-Mori Y
    Uchida N
    Wake A
    Taniguchi S
    Yoneyama A
    Pokaż więcej
    Źródło:
    Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2012 Aug; Vol. 14 (4), pp. 355-63. Date of Electronic Publication: 2012 Jan 30.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Hematologic Neoplasms/*complications
    Hemorrhage/*etiology
    Pneumonia, Bacterial/*microbiology
    Pneumonia, Bacterial/*mortality
    Stenotrophomonas maltophilia/*isolation & purification
    Adult ; Anti-Bacterial Agents/therapeutic use ; Blood/microbiology ; Culture Media ; Disease Progression ; Female ; Gram-Negative Bacterial Infections/complications ; Gram-Negative Bacterial Infections/drug therapy ; Gram-Negative Bacterial Infections/microbiology ; Gram-Negative Bacterial Infections/mortality ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Immunocompromised Host ; Incidence ; Japan/epidemiology ; Male ; Middle Aged ; Pneumonia, Bacterial/complications ; Pneumonia, Bacterial/drug therapy ; Time Factors ; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    One-year low-dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group.
    Autorzy:
    Oshima K; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
    Takahashi T
    Mori T
    Matsuyama T
    Usuki K
    Asano-Mori Y
    Nakahara F
    Okamoto S
    Kurokawa M
    Kanda Y
    Pokaż więcej
    Źródło:
    Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2010 Oct; Vol. 12 (5), pp. 421-7.
    Typ publikacji:
    Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Acyclovir/*analogs & derivatives
    Antiviral Agents/*therapeutic use
    Hematopoietic Stem Cell Transplantation/*adverse effects
    Herpes Zoster/*prevention & control
    Valine/*analogs & derivatives
    Acyclovir/therapeutic use ; Adolescent ; Adult ; Female ; Herpes Zoster/epidemiology ; Herpes Zoster/etiology ; Humans ; Incidence ; Male ; Middle Aged ; Prospective Studies ; Risk Factors ; Transplantation, Homologous ; Treatment Outcome ; Valacyclovir ; Valine/therapeutic use
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Monobactam and aminoglycoside combination therapy against metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a 'break-point checkerboard plate'.
    Autorzy:
    Araoka H; Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
    Baba M
    Takagi S
    Matsuno N
    Ishiwata K
    Nakano N
    Tsuji M
    Yamamoto H
    Seo S
    Asano-Mori Y
    Uchida N
    Masuoka K
    Wake A
    Taniguchi S
    Yoneyama A
    Pokaż więcej
    Źródło:
    Scandinavian journal of infectious diseases [Scand J Infect Dis] 2010 Mar; Vol. 42 (3), pp. 231-3.
    Typ publikacji:
    Case Reports; Journal Article
    MeSH Terms:
    Drug Resistance, Multiple, Bacterial*
    Aminoglycosides/*therapeutic use
    Anti-Bacterial Agents/*therapeutic use
    Monobactams/*therapeutic use
    Pseudomonas Infections/*drug therapy
    Pseudomonas aeruginosa/*drug effects
    beta-Lactamases/*biosynthesis
    Drug Therapy, Combination/methods ; Female ; Humans ; Japan ; Male ; Microbial Sensitivity Tests/methods ; Middle Aged ; Pseudomonas Infections/microbiology ; Pseudomonas aeruginosa/isolation & purification ; Sepsis/drug therapy ; Sepsis/microbiology ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-10 z 10

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies